Concepedia
Statistics
Publications
79
Citations
8.2K
H-Index
40
Active since
1995
Affiliations
Dana-Farber Cancer Institute(Current)
Harvard University
Massachusetts General Hospital
Beth Israel Deaconess Medical Center
Brigham and Women's Hospital
Erica L. Mayer is an author at Dana-Farber Cancer Institute specializing in oncology, medicine, and pharmacology.
Publications per year
1995–2025
Prevention and Monitoring of Cardiac Dysfunction in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline
Saro H. Armenian, Christina Lacchetti, Ana Barac et al. · Journal of Clinical Oncology · 2017 · 1.3K citations
Medicine, Cardiology, Oncology +16
Absence of blood formation in mice lacking the T-cell leukaemia oncoprotein tal-1/SCL
Ramesh A. Shivdasani, Erica L. Mayer, Stuart H. Orkin · Nature · 1995 · 955 citations
Life Sciences, Hematology, Molecular Biology +12
TBCRC 001: Randomized Phase II Study of Cetuximab in Combination With Carboplatin in Stage IV Triple-Negative Breast Cancer
Lisa A. Carey, Hope S. Rugo, P. Kelly Marcom et al. · Journal of Clinical Oncology · 2012 · 493 citations · Full text
Medicine, Oncology, Pharmacology +17
Adherence to Initial Adjuvant Anastrozole Therapy Among Women With Early-Stage Breast Cancer
Ann H. Partridge, Andrea LaFountain, Erica L. Mayer et al. · Journal of Clinical Oncology · 2008 · 487 citations
Pharmacy, Oncology, Pharmacotherapy +15
TBCRC009: A Multicenter Phase II Clinical Trial of Platinum Monotherapy With Biomarker Assessment in Metastatic Triple-Negative Breast Cancer
Steven J. Isakoff, Erica L. Mayer, Lei He et al. · Journal of Clinical Oncology · 2015 · 430 citations · Full text
1–5 of 79